Group items tagged

Buy Percocet Online Buy Percocet Online,the combination oxycodone/paracetamol is a combine opioid/non-opioid pain reliever use to treat moderate to severe acute pain, market by Endo International plc, formerly Endo Pharmaceuticals. Percocet has helped many people reclaim their lives from chronic pain that threatens to interfere with one's day and to sabatoge one's mood. Percocet is yet another pain reliever in the narcotic family, but is milder than morphine and other forms. It combines Oxycodone, a group of narcotics, with a milder form of pain reliever called acetaminophen, which is quite effective, and can intensify the drug's effects. While Percocet is quite safe and effective, it can be habit-forming and is not the kind of drug which should be given to just anyone. To avoid drug abuse, doctors often prescribe Percocet to responsible adults and caution patients to keep their medications in safe places away from children or those who may use the drug irresponsibly. Buy Percocet Online The combination of drugs in Percocet helps create a milder way of treating chronic pain. The medication can be use for intense pain or can be use in a slow-release formula to treat chronic pain that occurs constantly. When taking Percocet for chronic pain, it is important not to chew or crush the pill, but to swallow it with water, so the pill has the opportunity to digest and to work properly. Before a doctor can prescribe Percocet, he or she needs to be sure the patient is not allergic to oxycodone or toe acetaminophen. If a patient has a history of heart disease, or liver or kidney problems, there might be an issue with taking Percocet. In addition, a history of drug abuse will make someone unable to take the drug, since the doctor will not give Percocet to someone who will likely abuse it.

Haleon's Community Pharmacy Pain Consultations Programme, piloted in Australia, has shown promising potential for enhancing pharmacies' roles in pain management. Running from January to May 2023, the programme was designed and tested by the Haleon Centre for Human Sciences, recognising the pressing need to optimise pain consultations between patients and pharmacists. The used a series of simple interventions, rooted in behavioural science, aimed at improving patient experiences in pharmacies. These include window posters and floor graphics to disrupt habitual behaviours and reframe patients' perceptions of the pharmacist's role. Results measured by Professor Colin Strong, head of behavioral science at IPSOS, indicated a significant increase in patient preparedness for discussing pain. Specifically, 92 per cent of patients reported feeling more prepared for these conversations after the interventions, up from 71per cent before.

Try Pain O Soma for getting immediate Muscle Pain Relief!! We all undergo different sort of muscle pain, but every muscle pain arises due to twisting of tendons or disruption of tiny muscle fiber. The degree of muscle soreness varies from person to person and on severity of pain.

"Record long NHS waits are forcing huge numbers of people out of work, including doctors and nurses," said Wes Streeting MP, Labour's Shadow Health and Social Care Secretary as Labour announced a new partnership with Nuffield Health today to tackle joint pain issues among NHS staff and reducing waiting lists. Musculoskeletal problems, including back, knee, hip, and neck pain, are the second leading cause of NHS staff absences, surpassed only by mental health issues. In December 2023 alone, NHS workers missed a record 198,000 days due to these issues, marking a 13 per cent increase from the 174,000 days recorded in December 2019. Nurses and health visitors accounted for 52,000 of these days, up from 47,000 pre-pandemic, while doctors took 3,500 days off, a 9 per cent increase from 2019. The partnership with Nuffield Health will provide up to 4,000 extra places for NHS staff in Nuffield Health's Joint Pain Programme at no cost.

There's a "clear lack of awareness and understanding" of women's reproductive health conditions such as endometriosis, adenomyosis and heavy menstrual bleeding among primary healthcare practitioners, despite their widespread prevalence in the UK, according to a new report by the Women and Equalities Committee (WEC). This is causing considerable delays in diagnosis and treatment, leaving women and girls to "suck it up" and endure pain and discomfort, it stated. The report identifies pervasive stigma associated with gynaecological and urogynaecological health, a lack of education and 'medical misogyny' as factors contributing to poor awareness of these conditions. Labour MP Sarah Owen, chair of the Committee, said: "Our inquiry has shown misogyny in medicine is leaving women in pain and their conditions undiagnosed." "Women are finding their symptoms dismissed, are waiting years for life changing treatment and in too many cases are being put through trauma-inducing procedures. All the while, their conditions worsen and become more complicated to treat."

Females can be prone to lack of sexual pleasure and lack of sex drive and this decreases the number of times that they have sex with their partners. There are a lot of women who have various physical problems too. This includes those problems like increased bleeding during menstruation, increased duration of menstruation and also pain during menstruation.

As FSD can affect its victims in a countless number of different ways, this leads many people to think that you need to use a variety of remedies to treat your varying symptoms. This is not the case as you can Buy Lovegra Tablets online to treat your FSD with ease, whether your symptoms include a lack of arousal or ability to achieve orgasm, intense pain, and more.

A recent study presented at the European Congress on Obesity in Venice sheds light on the detrimental effects of obesity on workplace absenteeism and economic productivity. The analysis, encompassing data from millions of workers across Europe, reveals a direct correlation between body mass index (BMI) and the likelihood of taking sick leave. According to the study, obese individuals are up to twice as likely to take time off work due to health issues compared to those of a healthy weight. The increased sick notes among obese individuals is attributed to various complications associated with obesity, including joint pain, diabetes, depression, and heart disease. In the United Kingdom, where obesity rates are among the highest in Europe, the impact of obesity on workplace absenteeism is particularly pronounced.

Following the publication of a new study by the British Medical Journal (BMJ) that estimates the economic impact and prevelance of hazardous NSAID prescribing in England, the Royal Pharmaceutical Society (RPS) has underscored the pressing need for enhanced safety measures in medication management. The study, led by RPS Fellow Rachel Elliott, reveals significant health and financial costs associated with the high-risk prescribing of oral non-steroidal anti-inflammatory drugs (NSAIDs) among vulnerable populations. James Davies, Director for England at the RPS, emphasised the critical findings of the research. "Improving the safety of NSAID prescribing requires a multi-pronged approach, that educates and supports prescribers on the risk, as well as uses the skills of pharmacists in the primary care team to help identify higher risk patients and prescribing scenarios," Davies remarked. The study highlights that NSAIDs, while effective in managing pain and inflammation, are associated with serious adverse events, including gastrointestinal bleeding, renal dysfunction, and cardiovascular issues.

Researchers at Duke University, after analysing millions of patient visits to primary care physicians, found that mental health concerns are second only to musculoskeletal complaints, such as aches and pains, in everyday care. According to the study, one in nine patients sought care primarily for a mental health concern, a figure that increases to one in five for those in mid-life Published recently in Nature Mental Health, the study indicated that the prevalence of mental health concerns is nearly equal to that of respiratory and cardiovascular complaints, surpassing infections, injuries, digestive health, skin conditions, urological problems, and sensory issues. Led by Avshalom Caspi, the Edward M. Arnett Professor of Psychology and Neuroscience at Duke University, the researchers examined over 350 million primary care visits involving 4.8 million people from January 2006 to December 2019, as recorded by the Norwegian government. Caspi noted that 12 per cent of all encounters with primary care physicians were for mental health problems, i.e. more than 40 million mental health visits out of the total.

A new survey has highlighted growing concerns about pharmacists' increasing workload and their often-overlooked role within the healthcare systems. In the survey commissioned by consumer health company Kenvue, over 90 per cent of pharmacists reported a workload increase over the past year, with only 37 per cent considering their current workload sustainable. Their primary concerns include the impact of workload on wellbeing, expanding clinical roles and services, and challenges with staff recruitment and retention. Pharmacists reported spending most of their time advising patients on common ailments such as coughs, colds, pain, and allergies. However, they spend significantly less time on preventive services, which could further reduce pressure on the wider healthcare system. For instance, only seven pharmacists focus primarily on smoking cessation, and just four per cent on oral health. The survey also highlighted pharmacists' sense of being undervalued, with only 22 per cent feeling valued by policymakers, despite their significant contributions to primary care provision.

Health and Social Care Secretary Wes Streeting reiterated his commitment to reducing NHS waiting lists during his visit to Frimley Health NHS Foundation Trust's Heatherwood Hospital in Ascot on Friday. Streeting toured the Berkshire hospital, which is helping tackle backlogs of planned operations with dedicated surgical services, thereby cutting local waiting lists. The health secretary spoke to staff and patients at the hospital before meeting regional health representatives to discuss the issues facing services at a town hall event. His visit follows his recent call for an independent investigation into the NHS, pledging to be honest about the state of the health service and serious about fixing it. "The NHS is broken. Millions of patients are waiting too long for treatment, often in pain and discomfort," Streeting said.

A 58-year-old nurse from North Lanarkshire, Scotland, has reportedly died after taking the weight-loss drug tirzepatide, which was recently approved for use on the NHS. Susan McGowan died from multiple organ failure, septic shock and pancreatitis, with the use of the Eli Lilly drug listed as a contributing factor on her death certificate, according to the BBC. She had taken two low-dose injections of tirzepatide, known by the brand name Mounjaro, over a two-week period before her death on 4 September. Her death is thought to be the first in the U.K. officially linked to the drug. McGowan, who had worked for over 30 years as a nurse at University Hospital Monklands in Airdrie, purchased a prescription for the drug through a registered online pharmacy. A few days after her second injection, McGowen began experiencing severe stomach pains and sickness. She went to A&E at Monklands - where her colleagues tried to save her life. Within days, her kidneys failed, and she fell into a coma as her other organs began to fail.

Customs officials at Mundra port in Gujarat's Kutch district, India, recently seized approximately 6.8 million Tramadol tablets valued at Rs 110 crore (around GBP 10.2 million). The tablets were discovered in two export containers bound for Sierra Leone and Niger in West Africa. Tramadol, an opioid pain medication, was classified as a psychotropic substance under the Narcotic Drugs and Psychotropic Substances Act (NDPS Act) in 2018 and its export is now restricted. This synthetic opioid drug has gained notoriety in recent times as the "Fighter Drug" after it was reported that ISIS fighters used it to stay awake for long hours, said a PIB release on Monday. It is reportedly in high demand in African nations like Nigeria, Ghana, etc. The Mundra Customs seizure is one of the largest seizures of Tramadol since it was notified under the NDPS Act, said the release.

Indian pharmaceutical company Glenmark Life Sciences (GLS) has rebranded as Alivus Life Sciences, following its acquisition by consumer goods holding conglomerate Nirma Limited. It is a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas such as cardiovascular disease, central nervous system disease, pain management and diabetes. In March 2024, Nirma Limited, headquartered in Ahmedabad, India, acquired a 75 per cent majority stake in Glenmark Life Sciences, becoming the new promoter of the company. The pharmaceutical company has described the rebranding to Alivus Life Sciences as "an exciting new chapter" in its journey. In a press release, the company explained: "The change is reflective of the company's evolving vision aimed at further strengthening its global presence and a commitment to providing innovative solutions in the API and contract development and manufacturing organization (CDMO) space.

We know remuneration influences behaviour. If I have a construction company and I pay a bricklayer a fee per brick to supply and fit, I suspect he will source them from the cheapest supplier and lay as many bricks as he possibly can. If one day, I reduce the fee such that it barely covers the cost of the brick, at a time when bricks are in short supply and labour costs have gone up, oh and I take some money off him for the profit he made on bricks he supplied the previous year, I suspect he will tell me to stick my job where the sun doesn't shine. It may be a crude analogy, but it is pretty much what's happened in community pharmacy over the last 20 years. The remuneration we get for dispensing does not cover the cost of providing the service. The reimbursement for the drugs does not cover the cost of the drugs. In fact, we make a loss on many items given all the clawbacks and supply shortages. Wages have gone up. And then each year the government claws back profit they say we've made, apparently! Yet, despite all this, we continue providing the service under this archaic system, allowing our paymaster to repeat the injustice because they know they can and, unlike the bricklayer, we will just suck it up and take it. So, what makes us carry on like this? Is it our conscience towards patient care? Is it that we don't know what else to do and the fear of the unknown? Or is it like the boiling frog story, where the temperature has increased gradually around us that we haven't noticed the government heat slowly killing community pharmacy. I suspect the answer is a mixture of all these factors. The pain is somewhat masked when we see fee paying services